


To achieve long-term capital growth while maintaining an adequate spread of risk.
| Name | % Net Assets | 
|---|---|
| Vodafone Group | 6.6% | 
| HSBC Holdings | 5.9% | 
| BP | 5.5% | 
| GlaxoSmithKline | 5.2% | 
| Royal Bank of Scotland Group | 5.1% | 
| Shell Transport & Trading | 3.4% | 
| HBOS | 3.4% | 
| Barclays | 3.3% | 
| mmO2 | 2.0% | 
| AstraZeneca | 2.0% | 
| Key | % Net Assets | 
|---|---|
| 6.6% | |
| 5.9% | |
| 5.5% | |
| 5.2% | |
| 76.8% | 
| Date | 24-Feb-2017 | 
|---|---|
| NAV | 1,417.00p | 
| Currency | GBP | 
| Change | -1,251.81p | 
| % | -99.27% | 
| YTD change | 1,417.00p | 
| YTD % | n/a | 
| Fund Inception | 03/07/2000 | 
|---|---|
| Fund Manager | Morgan Stanley Investment Mgt Ltd | 
| TER | - | 
| Minimum Investment | |
|---|---|
| Initial | £250000 | 
| Additional | n/a | 
| Savings | n/a | 
| Charges | |
|---|---|
| Initial | 5.00% | 
| Annual Mang't | 0.80% | 
| Exit | n/a | 
| Name | % | 
|---|---|
| Standard deviation | 0.02 | 
| Sharpe ratio | 0.05 | 
You are here: research